FDA Approves Orexo for Treating Opioid Addiction

Source: PharmaManufacturing.com

Jul 08, 2013

Reuters

The U.S. Food and Drug Administration has approved Swedish drugmaker Orexo AB's drug to treat opioid addiction. The tablet, Zubsolv, combines the drugs buprenorphine and naloxone and will compete with similar products, Subutex and Suboxone, made by Britain's Reckitt-Benckiser Group Plc. Read the full story
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments